The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...
This revival of Lyle Kessler’s Philadelphia set play at Jermyn Street Theatre energetically tells the story of two orphan ...
New West Data hopes to scale up plan for off-grid generators that run on natural gas that would otherwise be flared or vented ...
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
If the weather forecast is to be believed, something miraculous is about to happen in San Francisco. For the first time in ...
Anime villains aren’t always meant to be hated. Sometimes, their pain, ideals, and resolve make them impossible not to root ...
Since the Trump regime’s recent assault on Venezuela, a lot of Americans have been talking more about the nature of their country. This is significant ...
Underneath the episodic storylines about diplomatic summits and training missions, Starfleet Academy is attempting to break ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – ...
AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...
"A listing on Nasdaq marks a defining moment in NervGen’s evolution as a leading biopharmaceutical company developing neuroreparative therapeutics," said Adam Rogers, MD, Interim Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback